AC
RPID icon

Armistice Capital’s Rapid Micro Biosystems RPID Stock Holding History

Armistice Capital’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.76M Buy
+3,328,000
New +$7.01M 0.07% 128

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EFA
Evernest Financial Advisors Carmel, Indiana $478M AUM 24% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital's RPID Position: Q2 2026 in Review

Armistice Capital opened a new position in Rapid Micro Biosystems (RPID) in Q2 2026: 3,328,000 shares worth $5.76M. The stake represents 0.07% of the portfolio and ranks #128 among its holdings.

32 funds tracked by Wall St. Rank hold RPID as of Q2 2026.

  • Armistice Capital held 3,328,000 shares of Rapid Micro Biosystems worth $5.76M as of Q2 2026.
  • Rapid Micro Biosystems was a new Armistice Capital position in Q2 2026.
  • Rapid Micro Biosystems made up 0.07% of Armistice Capital's portfolio in Q2 2026, its #128 holding.
  • 32 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.